#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15884	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2124	741.6	0	.	n	.	0	C451T	SNP	451	451	C	709	709	T	884	T,C	817,7	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15884	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2124	741.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1442	1442	C	929	C	873	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28588	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	803.7	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	897	C,T,G	839,8,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28588	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	803.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	931	C	866	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28588	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	803.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2905	2905	T	835	T,C	632,163	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28588	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	803.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	942	A	883	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2082	folP	855	855	100.0	folP.l15.c4.ctg.1	1697	122.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1065	1067	AGC	199;200;201	A;G;C	184;186;186	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	172.8	1	SNP	p	S91F	1	.	.	271	273	TTC	586	588	TTC	197;193;194	T;T,C;C	179;175,1;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	172.8	1	SNP	p	G95N	0	.	.	283	285	GGC	598	600	GGC	194;192;194	G,A;G,A;C	176,1;173,2;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	172.8	1	SNP	p	D95G	1	.	.	283	285	GGC	598	600	GGC	194;192;194	G,A;G,A;C	176,1;173,2;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1684	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1526	109.9	1	SNP	p	G45D	0	.	.	133	135	GGC	517	519	GGC	192;193;192	G;G;C	182;181;181	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	900	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1058	84.3	0	.	n	.	0	A197.	DEL	197	197	A	678	678	A	218	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5822	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2801	206.3	1	SNP	p	D86N	0	.	.	256	258	GAC	502	504	GAC	243;241;239	G;A;C	224;217;222	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5822	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2801	206.3	1	SNP	p	R87W	0	.	.	259	261	CGT	505	507	CGT	239;244;244	C,A,T;G;T	221,1,1;228;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5822	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2801	206.3	1	SNP	p	R87I	0	.	.	259	261	CGT	505	507	CGT	239;244;244	C,A,T;G;T	221,1,1;228;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5822	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2801	206.3	1	SNP	p	S87R	1	.	.	259	261	CGT	505	507	CGT	239;244;244	C,A,T;G;T	221,1,1;228;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5822	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2801	206.3	1	SNP	p	S88P	0	.	.	262	264	TCC	508	510	TCC	248;249;250	T;C;C	225;235;232	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4398	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2899	151.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1661	1663	GGC	205;203;205	G;G;C	193;194;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1162	1164	GCC	237;237;241	G;C;C,A	221;222;223,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1165	1167	ATG	244;244;242	A;T;GAA,GAAA	227;229;224,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1177	1179	ACC	243;245;247	A;C;C	221;224;227	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1177	1179	ACC	243;245;247	A;C;C	221;224;227	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1678	1680	ACC	258;259;255	A;C;C	234;238;240	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1732	1734	GCG	236;238;239	G;C;G	222;225;225	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1732	1734	GCG	236;238;239	G;C;G	222;225;225	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1855	1857	GGT	202;200;200	G;G;T,C	180;180;179,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1864	1866	AGC	185;181;180	A,G;G;C	169,1;165;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4208	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	177.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1882	1884	CCG	163;164;165	C,CG;C;G	127,1;130;134	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6136	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3213	190.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1662	1664	CCG	210;208;208	C;C;G	190;190;188	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2840	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1666	168.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	515	515	C	196	C	178	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2936	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1793	163.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	602	604	GTT	219;221;221	G,A;T,G;T	207,2;205,2;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2936	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1793	163.0	0	.	p	.	0	G50D	NONSYN	148	150	GGC	617	619	GAC	226;226;231	G;A,G;C	214;209,5;220	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2936	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1793	163.0	1	SNP	p	G120K	1	.	.	358	360	AAG	827	829	AAG	261;263;262	A;A;G	243;247;240	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2936	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1793	163.0	1	SNP	p	N121D	0	.	.	361	363	AAC	830	832	AAC	263;263;261	A,G;A;C,T	243,1;245;239,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2936	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1793	163.0	1	SNP	p	A121N	1	.	.	361	363	AAC	830	832	AAC	263;263;261	A,G;A;C,T	243,1;245;239,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10770	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4857	221.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1202	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1113	107.4	1	SNP	p	V57M	1	.	.	169	171	ATG	509	511	ATG	258;257;257	A;T;G	245;243;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
